Company Search:
Advanced Search
Sponsored Links
Retrophin Inc Company Snapshot
Retrophin Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Retrophin Inc with three other companies in this sector in the United States: MorphoSys AG (2015 sales of $117.16 million of which 56% was Proprietary Development), Foundation Medicine Inc ($93.20 million of which 100% was Diagnostic), and National Research Corporation ($102.34 million of which 100% was Performance Tracking).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Retrophin Inc
  Stock Performance Chart for Retrophin Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 20.58
(Figures in U.S. Dollars)
1 Week -3.6%   13 Weeks -8.8%  
4 Weeks 13.6%   52 Weeks 11.7%  
Retrophin Inc Key Data:
  Ticker: RTRX Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 99,892,000
(Year Ending Jan 2016).
Employees: 130
  Currency: U.S. Dollars Market Cap: 755,926,697
  Fiscal Yr Ends: December Shares Outstanding: 36,731,132
  Share Type: Common Closely Held Shares: 13,521,539
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.